deferasirox has been researched along with Cancer of Cervix in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, P; Chen, S; Cui, Y; Duan, X; Fan, Y; Hou, J; Kuang, Y; Ma, W; Tan, K; Xu, X; Zhou, N; Zhu, R; Zhu, Y | 1 |
1 other study(ies) available for deferasirox and Cancer of Cervix
| Article | Year |
|---|---|
Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo.
Topics: Animals; Benzoates; Deferasirox; Female; Humans; Iron; Iron Chelating Agents; Mice; Triazoles; Uterine Cervical Neoplasms | 2022 |